Screener

Eligibility screening

a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Sponsored by Marengo Therapeutics, Inc.Study detailsClinicalTrials.gov

18 US sites in CA, CO, FL, KS +10

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.